US 2004/0110693 A1 · Agent for treating diabetes mellitus

Abstract

Composition for the treatment of diabetes mellitus, comprising at least one plant bulk material in combination with at least one alpha-glucosidase inhibitor.

Claims37

Dependent claims

A composition for the treatment of diabetes mellitus, characterized in that it comprises at least one plant bulk material in combination with at least one alpha-glucosidase inhibitor.

Dependencies are inferred from the claim text.

Facts

Application

10/468,409Filed 21 Jan 2004

Priority

DE 101 10 124.42 Mar 2001

Published

10 Jun 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61K 31/133
Amines: having hydroxy groups, e.g. sphingosine
A61K 31/7008
Carbohydrates; Sugars; Derivatives thereof: compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g.…
A61K 31/702
Carbohydrates; Sugars; Derivatives thereof: oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic…

Abstract

Composition for the treatment of diabetes mellitus, comprising at least one plant bulk material in combination with at least one alpha-glucosidase inhibitor.

Agent for treating diabetes mellitus

Life of this patent

Abstract

Claims37

Agent for treating diabetes mellitus

Life of this patent

Abstract

Claims37